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Abstract
The relationship between physical activity and breast cancer risk has been extensively studied 
among women of European descent, with most studies reporting inverse associations. However, 
data on American women of African ancestry (AA) and by tumor subtypes are sparse. Thus, we 
examined associations of vigorous exercise and breast cancer risk overall, and by estrogen receptor 
(ER) status, in the African American Breast Cancer Epidemiology and Risk Consortium. We 
pooled data from four large studies on 2482 ER+ cases, 1374 ER− cases, and 16,959 controls. 
Multivariable logistic regression was used to compute odds ratios (OR) and 95 % confidence 
intervals (CI) for the risk of breast cancer overall, and polytomous logistic regression was used to 
model the risk of ER+ and ER− cancer. Recent vigorous exercise was associated with a 
statistically significant, modestly decreased risk for breast cancer overall (OR 0.88, 95 % CI 0.81–
0.96) and for ER+ cancer (OR 0.88, 95 % CI 0.80–0.98), but not for ER− cancer (OR 0.93, 95 % 
CI 0.82–1.06). Overall, there was no strong evidence of effect modification by age, menopausal 
status, body mass index, and parity. However, our data were suggestive of modification by family 
history, such that an inverse association was present among women without a family history but 
not among those with a relative affected by breast cancer. Results from this large pooled analysis 
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provide evidence that vigorous physical activity is associated with a modestly reduced risk of 
breast cancer in AA women, specifically ER+ cancer.
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Introduction
Breast cancer remains the most common cancer and the second leading cause of cancer 
death in US. women [1]. American women of African ancestry (AA) are more likely than 
women of European ancestry (EA) to be diagnosed with breast cancer at younger ages, to 
have more aggressive estrogen receptor (ER)-negative cancers, and to die from breast cancer 
[2]. There has been a considerable amount of research in identifying risk factors for breast 
cancer, but most of the established risk factors, such as age, family history of breast cancer, 
genetic susceptibility, benign breast disease, early menarche and late menopause [3], are not 
modifiable. Physical activity is amenable to change and, therefore, represents an opportunity 
to reduce the burden of breast cancer, especially among AA women, who have been found to 
meet recommendations for physical activity less frequently compared with EA women [4, 
5].
Numerous studies over the past two decades, mostly among EA women, have examined the 
association between physical activity and breast cancer risk. Although findings have been 
mixed, especially from cohort studies, previous, and recent reviews, including the 2007 
World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) report 
and the 2010 WCRF/AICR Continuous Update, have generally concluded that the evidence 
is “convincing” [6, 7] or at least “probable” [8, 9] for an inverse association between 
physical activity and breast cancer risk in postmenopausal women. The evidence in 
premenopausal women has been limited and generally weaker [7–9]. Many aspects 
regarding the physical activity breast cancer association remain unclear. Results on whether 
associations differ according to subtype of breast cancer have been conflicting, but several 
large studies have found strong associations for ER+ cancer [10–12]. Inconsistencies also 
remain regarding modifying effects of other risk factors, such as family history of breast 
cancer, body mass index (BMI), and reproductive factors. Insofar as most studies have 
focused primarily on EA women, data on physical activity and breast cancer, especially by 
subtype, are needed for AA women [7].
In this study, we investigated the role of recent physical activity in the risk of breast cancer 
overall and by tumor ER status in AA women, using data from a large project, the African 
American Breast Cancer Epidemiology and Risk (AMBER) Consortium. We also examined 
whether these associations differed by age, menopausal status, family history, BMI, and 
parity.
Gong et al. Page 2
Breast Cancer Res Treat. Author manuscript; available in PMC 2017 April 21.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Materials and methods
Study population
The AMBER Consortium, a collaborative project of four studies, the Black Women’s Health 
Study (BWHS), the Multiethnic Cohort Study (MEC), the Carolina Breast Cancer Study 
CBCS), and the Women’s Circle of Health Study (WCHS), was formed in 2011 and 
designed to advance understanding of the determinants of breast cancer risk in AA women, 
with details described previously [13–17]. Briefly, the BWHS is an ongoing prospective 
cohort study, with AA women across the US. enrolled in 1995 and then followed every two 
years through mailed questionnaires. Breast cancer cases are identified by self-report or 
through linkage with state cancer registries. The MEC is also a prospective cohort study that 
began in 1993, with participants recruited from Hawaii and Southern California, with AAs 
primarily from California; cases are identified by linkage to the Hawaii Tumor Registry, the 
Cancer Surveillance Program for Los Angeles County and the California State Cancer 
Registry. Each cohort study created nested case-control studies sets that included incident 
breast cancer cases together with controls frequency matched to the cases by five-year age 
category; data were taken from questionnaires completed prior to case diagnosis (index 
date). CBCS, in the first two phases (CBCS 1 & 2), conducted with population-based 
sampling and in-person interviews in North Carolina from 1993 to 2001. CBCS 3 is ongoing 
and includes cases only, thus is not included in this analysis. Breast cancer cases in CBCS 
were identified through the North Carolina Central Cancer Registry by rapid case 
ascertainment, with oversampling of younger cases. Controls enrolled in CBCS 1 and 2 were 
identified from Division of Motor Vehicle lists (age <65 years) and from Health Care 
Financing Administration lists (age 65 years or older). The WCHS is a case-control study 
that started in New York City (NYC) and currently recruits AA women in New Jersey (NJ) 
only. Breast cancer cases were identified using hospital-based case ascertainment in targeted 
hospitals in the NYC area from 2002 to 2008 and by population-based rapid case 
ascertainment in NJ since 2006 through the NJ State Cancer Registry. Controls were 
identified through random digit dialing and supplemented by community-based recruitment 
efforts [18]. Pooled data from the four studies resulted in a total of 4416 invasive breast 
cancer cases and 16,959 controls after exclusion of women with missing values for vigorous 
physical activity (n = 606).
Data collection
Information including demographic factors, family history of breast cancer, reproductive and 
medical history, hormone use, lifestyle factors, and weight and height were collected at 
baseline and updated every two years for BWHS and every five years for MEC by mail 
questionnaire. Data for these factors were collected in CBCS and WCHS by in-person 
interviews. Immunohistochemistry results of breast cancer were obtained from hospital 
pathology records and cancer registry data, and were used to classify cases as ER+ and ER− 
breast cancer. Each study was approved by the relevant Institutional Review Boards and 
obtained informed consent from all participants. Data on key variables from each study were 
harmonized at the coordinating center. Many of the variables (e.g., age, education, family 
history, body mass index, and female hormone use) were asked in these studies using similar 
questions. For some variables (e.g., age at first birth, age at menopause), categories were 
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collapsed so as to have categories common to all the studies. For variables in which there 
was some question as to how to harmonize the variable (e.g., physical activity), the study 
investigators, with the data coordinating center staff, discussed and mutually agreed upon the 
most appropriate categorization (see below).
Vigorous recreational physical activity
We harmonized data on recent vigorous recreational physical activity as follows. In BWHS, 
participants were asked to report the average number of hours per week they spent on 
vigorous activity (e.g., basketball, bicycling on hills, running, swimming, and aerobics). 
Response options were 0, <1, 1, 2, 3–4, 5–6, 7–9, and 10+ h/week. In MEC, participants 
reported their average hours per week spent on vigorous exercise (e.g., jogging, bicycling on 
hills, tennis, racquetball, swimming laps, and aerobics) in categories of never, ½ to 1, 2–3, 
4–6, 7–10, 11–20, 21–30, and 31+ h/ week. In CBCS 1 and 2, participants were asked to 
report activities that they engaged in regularly on a weekly basis to keep them physically fit 
and to describe how often they participated in that activity. The response options were 1) 
daily (7 days); 2) several times (5–6 times); 3) every other day (3–4 times); and 4) once or 
twice (1–2 times) a week. We then converted the number of days of activity (using the 
lowest number of days in the range) to hours per week by assuming that participants 
engaged in an average of 45 min of the reported activity each day. This assumption was 
based on comparisons of the distributions of activity patterns in CBCS 1 and 2 with data 
collected in CBCS 3, which collected continuous measures of vigorous physical activity. A 
sensitivity analysis was performed to test the impact of these assumptions. In WCHS, 
participants reported any activities they participated in for at least one hour per week for at 
least three months. A metabolic equivalent of energy expenditure (MET) value was assigned 
to each reported activity according to the Compendium of Physical Activity [19, 20]. 
Participants were asked to report any activities they engaged in, and data were recorded on 
the type of activity, the number of years in total for the activity, the number of months per 
year, and the average hours per week. Average hours per week were then computed for 
vigorous activity, defined as activities with a MET value of 6.0 or greater. We assessed 
various categorizations of physical activity, including 0, <2, 2–6, and 7+ h/week, and due to 
small numbers (n = 86 cases) in the 7+ category, categories were further collapsed down to 
0, <2, and 2+ h/week in models examining potential effect modification by several breast 
cancer risk factors.
Statistical analysis
Multivariable unconditional logistic regression was used to estimate odds ratios (ORs) and 
95 % confidence intervals (CIs) for the association between vigorous activity and risk of 
breast cancer. The potential confounding factors included in the multivariable models were 
age (continuous), study (BWHS, MEC, CBCS, WCHS), geographic region (South, Midwest, 
West, New Jersey, other Northeast), time period (1993–98, 1999–2005, 2006–2014), 
education (<12, 12, 13–15, 16, >16 years), first-degree family history of breast cancer (yes, 
no), age at menarche (<11, 11–12, 13–14, 15–16, ≥17 years), BMI (<18.5, 18.5–24.9, 25.0–
29.9, 30.0–34.9, 35–39.9, and 40+ kg/ m2), menopausal status and age at menopause (pre-
menopausal, ages <45, 45–49, 50–54, or ≥55 years, or menopausal status undetermined), 
parity (0, 1, 2, 3, 4, 5, 6, ≥7), cigarette smoking (0, <10, 10–19, ≥20 pack years), alcohol 
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consumption (never, past drinkers, current drinkers at <1, 1–3, 4–6, 7–13, 13–20, 21+ drinks 
per week), and female hormone use (ever, never). Women who reported no vigorous activity 
were used as the referent group. Polytomous logistic regression models were used for 
examining the associations for ER+ and ER− breast cancer. In addition to the case-control 
analyses, case-case analyses were performed to estimate ORs for the association of vigorous 
physical activity to ER− relative to ER+ breast cancer.
Tests for a linear trend across categories of hours per week of vigorous physical activity 
were done using an ordinal variable corresponding to rank from lowest to highest category, 
as described by Breslow and Day [21]. To test whether the association between vigorous 
activity and breast cancer risk was modified by other factors, we performed the likelihood 
ratio test by comparing two multivariable-adjusted logistic regression models. We examined 
effect modification by age (<50 years vs ≥50 years), menopausal status (premenopausal 
versus postmenopausal), first-degree family history of breast cancer (yes vs no), BMI (<30 
kg/m2 vs ≥30 kg/m2), and parity (nulliparous vs parous). In addition, heterogeneity between 
studies was tested using Cochran’s Q statistic. A sensitivity analysis was also performed to 
evaluate the impact of our assumptions in computing CBCS physical activity variables; 
specifically, we compared findings from analyses in which CBCS was included to those 
after exclusion of CBCS.
All analyses were conducted using SAS V9.4 (SAS Institute, Cary, CA). Statistical tests 
were two-sided and considered statistically significant for P <0.05.
Results
Selected characteristics of breast cancer cases and controls are presented in Table 1. Among 
the 3856 (87.3 %) breast cancer tumors with known ER status, 2482 (64.4 %) were ER+ and 
1374 (35.6 %) were ER−, with 32 % of cases diagnosed before age 50. The CBCS, designed 
to oversample younger AA women, had the highest proportion of ER− breast cancer. In 
contrast, MEC has an older population and the highest prevalence of ER+ breast cancer. The 
highest prevalence of engaging in vigorous physical activity was observed in CBCS women, 
whereas the lowest prevalence was found among WCHS participants. The prevalence of 
vigorous activity was similar for MEC and BWHS participants.
Associations of recent vigorous physical activity with risk of breast cancer overall and by 
ER status are presented in Table 2. Overall, women who had engaged in vigorous exercise 
had a significantly decreased risk of breast cancer (OR 0.88, 95 % CI 0.81–0.96) compared 
with women who did not engage in any vigorous exercise. There was a statistically 
significant inverse trend across categories of hours per week of vigorous activity (p trend = 
0.007), but there was no clear dose–response relationship. Relative to no vigorous exercise, 
the ORs were 0.90 (95 % CI 0.81–1.01), 0.88 (95 % CI 0.79–0.98), and 0.86 (95 % CI 0.68–
1.10) for the activity categories <2, 2–6, and 7+ h/ week, respectively. For the combined 
category of >=2 h/ week, the OR was 0.88 (95 % CI 0.79–0.97) (data not shown). In the 
analysis by ER status, the inverse association associated with vigorous exercise (any vs 
none) was statistically significant for ER + cancer (OR 0.88, 95 % CI 0.80–0.98), but not for 
ER− breast cancer (OR 0.93, 95 % CI 0.82–1.06). However, when we compared ER− with 
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ER+ breast cancer in case–case analyses, there were no significant differences in risk 
patterns by ER status (Table 2).
We examined whether these associations were modified by age, menopausal status, family 
history, BMI, and parity. As shown in Table 3 for breast cancer overall, we found no 
statistically significant interactions for any of these associations in the analysis. However, 
results suggested that the pattern of association may differ for women with and without a 
first-degree family history of breast cancer (p interaction = 0.09). The inverse association 
associated with any vigorous exercise was present among women without a family history 
(OR 0.86, 95 % CI 0.79–0.94), but not among those with a relative affected by breast cancer 
(OR 1.04, 95 % CI 0.82–1.30). In addition, a significant inverse association was observed 
among premenopausal women, those with BMI <30 kg/m2, parous women, and in women 
ages <50 and ages >= 50. As shown in Table 4, we found generally similar association 
patterns for ER+ cancer and total breast cancer. There was suggestive evidence that the 
association of physical activity with ER+ cancer was modified by family history (p 
interaction = 0.07).
Statistical tests indicated that there were no significant differences between studies in the 
meta-analysis (p heterogeneity >0.05). Sensitivity analyses showed that the estimates 
remained largely the same after exclusion of CBCS participants from the primary analysis 
(ORs for <2, 2–6, 7 + h/week: 0.93, 0.86, 0.87; data not shown).
Discussion
In this large pooling study of breast cancer in AA women, we observed that any recent 
vigorous physical activity was associated with a modest, but statistically significant 
decreased risk of breast cancer, especially ER + cancer, although the difference by ER status 
was not statistically significant. There was not a clear dose–response relationship of 
decreasing breast cancer risk with increasing physical activity. In particular, the estimates of 
association for the categories <2, 2–6, and 7+ were similar. We found no strong evidence 
that age, menopausal status, BMI, and parity modified the association between recent 
vigorous physical activity and breast cancer. However, there was suggestive evidence of 
modification by family history, such that an inverse association was present among women 
without a family history but not among those with a family history of breast cancer.
Many studies, in populations mostly of EA women, suggest that physical activity is inversely 
associated with breast cancer risk, with stronger evidence observed in postmenopausal than 
in premenopausal women [22]. Inverse associations are strongest for vigorous recreational 
physical activity, as reported in a recent meta-analysis [23]. Data on AA women are limited, 
with few studies that have specifically examined the association in an AA population or 
populations that include adequate AA representation [10, 12, 24–29]. High levels of 
vigorous activity during early adult years or at study baseline were associated with 
decreased risk of breast cancer in two previous analyses in the BWHS (716 and 1330 AA 
cases, respectively) [24, 29]. An inverse association was observed for lifetime recreational 
physical activity in a large case-control study (1605 AA cases) [10], and for lifetime total 
activity in another study (394 AA cases) [25]; with both studies, finding no differences by 
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menopausal status. Recent recreational physical activity was inversely associated with breast 
cancer for both pre- and postmenopausal women in two small case-control studies (97 and 
88 AA cases, respectively) [26, 27], and for postmenopausal women in another larger study 
(660 AA cases) [12]. There was no association for recent recreational or other type of 
physical activity in the Southern Community Cohort, but those results were based on only 
313 AA cases [28]. Thus, there is no strong evidence to conclude that an association of 
physical activity with reduced risk of breast cancer in AA women differs by menopausal 
status.
Our study of AA women included a large number of ER− breast cancer cases. The inverse 
association was stronger and statistically significant for ER+ cancer, although the difference 
by ER status was not statistically significant. Previous studies of physical activity and breast 
cancer by ER status generally found no statistically significant difference in risk by ER 
status in pre- or post-menopausal women [11, 26, 29–36]. However, several of the large 
studies suggested a stronger inverse association for ER+ breast cancer [10–12, 31, 34, 37], 
including the two studies that conducted analysis by ER status in a larger AA population 
[10, 12]. In contrast, two studies reported a significant inverse association for ER− breast 
cancer in postmenopausal women [38, 39]. The observed inverse physical activity-breast 
cancer association is generally modest, and power from most studies has been limited to 
detect differences by ER status.
A number of studies have explored whether the physical activity breast cancer association is 
modified by other risk factors of breast cancer, including age, BMI, family history and 
parity, with mixed results [22]. In the current study of AA women, there was suggestive 
evidence that a family history of breast cancer may modify the association between vigorous 
activity and breast cancer. Several studies [10, 38, 40], although not others [26, 41], have 
reported similar results as ours that a significant decreased risk of breast cancer was 
observed among women with no family history of breast cancer and with no risk reduction 
observed for those with a family history. Several mechanisms by which physical activity 
could reduce risk of breast cancer have been proposed, including changes in menstrual 
characteristics, reduction of fat mass, lowering the production and bioavailability of 
endogenous hormones such as estrogen and insulin, and modulation of chronic inflammation 
and the immune system [42, 43]. It may be easier to detect a small difference in risk 
attributable to physical activity among women at lower baseline risk of breast cancer, such 
as women without a family history. In addition, genetic factors associated with family 
history may confer a unique susceptibility to hormonal derangements or other underlying 
mechanisms. Serum concentrations of estradiol and estrone have been shown to be higher in 
women with a family history of breast cancer [44]. Thus, family history may belie other 
differences between women that may mediate the effects of physical activity. This also could 
be explained as limited power due to small sample size of women who had a first-degree 
family history of breast cancer in these studies.
This study has several strengths. It is the largest study assessing physical activity and risk of 
breast cancer overall and by tumor subtypes, specifically in AA women. Extensive data were 
collected on various risk factors, enabling us to adjust for potential confounding and to 
further examine possible effect modification. However, there are also limitations. Physical 
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activity was self-reported, and data were pooled from four studies with differences in 
physical activity assessment, which hampered our ability to examine lifetime, other types 
(e.g., occupational and household activity) or total physical activity. However, we were able 
to evaluate recent vigorous physical activity, the type of activity most consistently shown to 
be associated with reduced breast cancer risk [8, 23], and uniformly collected in AMBER. 
Vigorous-intensity physical activity may be more accurately reported than lower-intensity 
activities and therefore resulting in less random misclassification. In addition, our 
assumption about the duration of exercise for CBCS participants was based on data collected 
in a later phase of CBCS and may have overestimated physical activity levels. Indeed, 
prevalence of the highest activity levels was greater in CBCS than in all the other studies. 
However, excluding CBCS did not substantially alter the findings.
In summary, this large study provides further epidemiologic evidence that recent vigorous 
activity is associated with a decreased risk of breast cancer in AA women. Specifically, two 
or more hours per week of vigorous activity may be sufficient to reduce risk. It may be more 
feasible to modify physical activity than to modify obesity, making physical activity a 
promising target for intervention to reduce the burden of this most common cancer among 
women.
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